NEUP
Price
$6.80
Change
-$0.20 (-2.86%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
12.78M
SLNO
Price
$83.99
Change
-$1.80 (-2.10%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
4.23B
40 days until earnings call
Interact to see
Advertisement

NEUP vs SLNO

Header iconNEUP vs SLNO Comparison
Open Charts NEUP vs SLNOBanner chart's image
Neuphoria Therapeutics
Price$6.80
Change-$0.20 (-2.86%)
Volume$2.15K
Capitalization12.78M
Soleno Therapeutics
Price$83.99
Change-$1.80 (-2.10%)
Volume$11.65K
Capitalization4.23B
NEUP vs SLNO Comparison Chart in %
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SLNO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Buy and SLNO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (NEUP: $6.80 vs. SLNO: $84.02)
Brand notoriety: NEUP and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 241% vs. SLNO: 127%
Market capitalization -- NEUP: $12.78M vs. SLNO: $4.23B
NEUP [@Biotechnology] is valued at $12.78M. SLNO’s [@Biotechnology] market capitalization is $4.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, NEUP is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 6 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • NEUP’s TA Score: 6 bullish, 4 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEUP is a better buy in the short-term than SLNO.

Price Growth

NEUP (@Biotechnology) experienced а +2.72% price change this week, while SLNO (@Biotechnology) price change was +5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

NEUP is expected to report earnings on May 20, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($4.23B) has a higher market cap than NEUP($12.8M). NEUP YTD gains are higher at: 98.251 vs. SLNO (86.919). NEUP has higher annual earnings (EBITDA): 192K vs. SLNO (-194.63M). SLNO has more cash in the bank: 290M vs. NEUP (17M). NEUP has less debt than SLNO: NEUP (172K) vs SLNO (52.8M). NEUP has higher revenues than SLNO: NEUP (15.7M) vs SLNO (0).
NEUPSLNONEUP / SLNO
Capitalization12.8M4.23B0%
EBITDA192K-194.63M-0%
Gain YTD98.25186.919113%
P/E Ratio0.36N/A-
Revenue15.7M0-
Total Cash17M290M6%
Total Debt172K52.8M0%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPSLNO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SACH1.100.02
+1.85%
Sachem Capital Corp
NWE51.170.37
+0.73%
NorthWestern Energy Group
PHG24.080.16
+0.67%
Koninklijke Philips NV
CATX3.62-0.19
-4.99%
Perspective Therapeutics
PHGE0.45-0.03
-6.05%
BiomX Inc

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-2.86%
SYBX - NEUP
64%
Loosely correlated
+1.67%
BRNS - NEUP
50%
Loosely correlated
+4.43%
CMND - NEUP
31%
Poorly correlated
-2.03%
ENSC - NEUP
31%
Poorly correlated
+1.83%
SLNO - NEUP
27%
Poorly correlated
-2.06%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-2.06%
BRNS - SLNO
56%
Loosely correlated
+4.43%
KANT - SLNO
45%
Loosely correlated
-2.44%
SYRE - SLNO
43%
Loosely correlated
+3.96%
NKTX - SLNO
42%
Loosely correlated
-2.81%
SVRA - SLNO
40%
Loosely correlated
+0.91%
More